Legend Biotech (LEGN) Amortization of Goodwill (2024 - 2025)
Legend Biotech (LEGN) posted Amortization of Goodwill of $970000.0 for Q1 2025, up 22030.82% on a QoQ basis from -$4423.0 in Q4 2024.
Legend Biotech (LEGN) has 2 years of Amortization of Goodwill data on file, last reported at $970000.0 in Q1 2025.
- In Q1 2025, Amortization of Goodwill changed N/A year-over-year to $970000.0; the TTM figure through Sep 2025 stood at $965577.0 (changed N/A YoY), while the FY2024 annual figure was -$4423.0, changed N/A from the prior year.
- Amortization of Goodwill advanced to $970000.0 in Q1 2025, from -$4423.0 in the prior quarter.
- Across five years, Amortization of Goodwill topped out at $970000.0 in Q1 2025 and bottomed at -$4423.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -970,000.00 |
| Mar 31, 2025 | -970,000.00 |
| Dec 31, 2024 | -4,423.00 |
| Dec 31, 2024 | -4,423.00 |